Table 3.

Reasons for Arginine Vasopressin (AVP) Avoidance and Alternate Medications Used Among Non-Users.

AVP avoidance and alternate medications	% Among non-users
Alternative agents to AVP
Norepinephrine	85.2%
Phenylephrine	14.8%
Primary reason AVP not used among non-users*
AVP not available	27.2%
Concern about potential adverse events	25.9%
Absence of clear indication for use	22.2%
Absence of evidence suggesting improved	14.8%
outcomes compared to other agents
Other	7.4%
No response	2.5%

^(*)More than one response accepted.